Phase
Condition
Cancer
Breast Cancer
Treatment
Walking Group
Grounding Group
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 years of age or older,
Can read and write and speak Turkish,
Diagnosed with primary breast cancer and know the diagnosis,
Volunteered to participate in the research,
Living in Ankara province,
Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated,
Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1,
NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2,
You have a phone with an iOS or Android processor,
Exclusion
Exclusion Criteria:
Open wounds or edema of the hands and feet,
NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5,
People with a disability that would prevent them from walking,
Diagnosed cardiovascular and pulmonary disorders,
Diagnosed neurological or psychiatric illness,
Communication problems,
Bone metastases,
Bilateral mastectomies,
Criteria for Withdrawal from the Study:
Withdrawal from the study at any stage,
Hospitalization,
Failure to follow the guidelines or perform the intervention-walking for 30 minutesat least three times a week or walking plus grounding-in the intervention group,
Starting a regular exercise program during the study period in the control group.
Study Design
Study Description
Connect with a study center
Gazi University Health Research and Application Center Gazi Hospital
Ankara,
TurkeyActive - Recruiting
Gazi University Health Research and Application Center Gazi Hospital
Ankara,
Turkey (Türkiye)Site Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.